![]() | ![]() |
Formats:
|
||||||||||||||||||||
Copyright © 2007 by The National Academy of Sciences of the USA Statistics, Biophysics Intracellular crowding defines the mode and sequence of substrate uptake by Escherichia coli and constrains its metabolic activity *Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261; †The Simons Center for Systems Biology, Institute for Advanced Study, Princeton, NJ 08540; §Machine Learning Department, Carnegie Mellon University, Pittsburgh, PA 15217; ¶Instituto de Física, Universidade Federal Fluminense, 24210, Rio de Janeiro, Brazil; and ‖Department of Physics and Center for Complex Networks Research, University of Notre Dame, Notre Dame, IN 46556 ‡To whom correspondence may be addressed. E-mail: vazquez/at/ias.edu **To whom correspondence may be addressed at: University of Pittsburgh, S701 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261. E-mail: oltvai/at/pitt.edu Edited by Gregory A. Petsko, Brandeis University, Waltham, MA, and approved May 31, 2007 Author contributions: Q.K.B. and A.V. contributed equally to this work; Q.K.B., A.V., M.A.d.M., A.-L.B., and Z.N.O. designed research; Q.K.B. and A.V. performed research; Q.K.B. and A.V. contributed new reagents/analytic tools; Q.K.B., A.V., J.E., and Z.B.-J. analyzed data; and Q.K.B., A.V., Z.B.-J., A.-L.B., and Z.N.O. wrote the paper. Received November 7, 2006. This article has been cited by other articles in PMC.Abstract The influence of the high intracellular concentration of macromolecules on cell physiology is increasingly appreciated, but its impact on system-level cellular functions remains poorly quantified. To assess its potential effect, here we develop a flux balance model of Escherichia coli cell metabolism that takes into account a systems-level constraint for the concentration of enzymes catalyzing the various metabolic reactions in the crowded cytoplasm. We demonstrate that the model's predictions for the relative maximum growth rate of wild-type and mutant E. coli cells in single substrate-limited media, and the sequence and mode of substrate uptake and utilization from a complex medium are in good agreement with subsequent experimental observations. These results suggest that molecular crowding represents a bound on the achievable functional states of a metabolic network, and they indicate that models incorporating this constraint can systematically identify alterations in cellular metabolism activated in response to environmental change. Keywords: flux balance analysis, metabolic networks, systems biology An important aim of systems biology is the identification of the organizing principles and fundamental constraints that characterize the function of molecular interaction networks and the limits of an organism's phenotypic diversity (1–3). Flux balance-based modeling approaches, combining the constraints imposed by the metabolic network's structure with, e.g., mass- or energy-conservation principles (3–6), are especially successful in providing experimentally testable predictions on an organism's metabolic flux state and growth rate. A relative shortcoming of these approaches, however, is that they do not take into account the physical and spatial constraints resulting from the cell's unique intracellular milieu (7–9). For example, ≈20–30% of the Escherichia coli cytoplasm is occupied by macromolecules, many of them enzymes, whose cytoplasmic concentration cannot be further increased without drastically affecting protein folding, protein–protein association rates, biochemical reaction kinetics, and transport dynamics within a cell (9, 10). This suggests that constraint-based modeling approaches, such as flux balance analysis (FBA) (3, 11), could be improved if we take into account that the enzymes catalyzing each reaction compete for the available cytoplasmic space (12, 13), potentially limiting the attainable flux rates. Current flux balance-based modeling approaches also have limited ability to predict substrate uptake from the environment. Extensive experimental data indicates that when grown in complex medium bacterial cells use the available substrates either preferentially or simultaneously depending on the growth condition (see, e.g., refs. 14–17). Efforts to model mixed-substrate growth have assumed specific kinetic expressions for substrate uptake and biomass growth rates, and their predictions are formulated in terms of known model parameters (15, 18). Similarly, FBA predictions are based on previous knowledge of the maximum uptake rates in the corresponding medium (the actual variables one aims to predict), and, in contrast to empirical evidence, FBA in itself predicts the simultaneous utilization of all carbon sources from a mixed-substrate growth medium. One way to overcome this deficiency is the superposition of regulatory mechanisms (in the form of mRNA expression signatures) on the FBA model, assessing which substrates are taken up and which are not (19). Yet regulatory mechanisms appear during the course of evolution because they result in a selective advantage for the cell. This selective advantage results from better use of the available resources within the metabolic constraints of the organism. Therefore, the metabolic constraint can be considered as the primary cause, whereas the regulatory processes represent the specific molecular mechanism developed to cope with this constraint. This fact opens the possibility for a FBA model that, after imposing the relevant constraints, predicts the selective advantage of implementing a regulatory mechanism. Here, we develop a modified FBA model that incorporates a solvent capacity constraint for the attainable enzyme concentrations within the crowded cytoplasm. Using this model, we predict the maximum growth rate of E. coli MG1655 wild-type and mutant strains on single carbon sources and for the dynamic patterns of substrate utilization from a mixed-substrate growth medium. We test the model predictions by using growth rate measurements and microarray and substrate concentration temporal profiles, and we obtain a good agreement between model predictions and experimental measurements. Taken together, these results suggest that macromolecular crowding indeed imposes a physiologically relevant constraint on bacterial metabolic activity and that incorporating this constraint allows for improved modeling of cell metabolism from system-level principles. Results FBA with Molecular Crowding. In the flux balance model of cellular metabolism a cell's metabolic network is mathematically represented by the stoichiometric matrix, Smi, providing the stoichiometric coefficient of metabolite m (m = 1, …, M) in reaction i (i = 1, …, N) (3, 20), where M and N are the number of metabolites and reactions, respectively. The cell is assumed to be in a steady state, where the concentration of each intracellular metabolite (other than the metabolites that constitute the biomass) remains constant in time. Thus, the stationary reaction rates (fluxes) consuming and producing a metabolite should balance,
We extend this framework to consider the physical and spatial constraints resulting from the very high intracellular concentration of macromolecules (7–9). Given that the enzyme molecules have a finite molar volume vi, we can fit only a finite number of them in a given volume V. Indeed, if ni is the number of moles of the ith enzyme, then
FBAwMC Predicts the Relative Maximum Growth of E. coli Growing on Single Carbon Sources. To examine the validity of macromolecular crowding as a constraint on a cell's metabolic activity, and to test the predictive capability of the FBAwMC framework, we first examined the phenotypic consequences of extracellular substrate availability during growth in single carbon-limited medium with oxygen being in abundance, focusing on the maximum growth rate. The FBAwMC contains as a free parameter the average crowding coefficient a , and the model predictions for the maximum growth rate are proportional to a . We first assumed that a is a constant independent of the substrates. In this case it is possible to make predictions for the maximum growth rate in different substrates in arbitrary units. To obtain the maximum growth rates in specific units we fit a to minimize the mean-square deviation between the predicted and measured growth rates, resulting in a = 0.0040 ± 0.0005 h·g/mmol, in which g is grams of dry weight. We have obtained an independent estimate of ai for ≈100 E. coli enzymes as well [supporting information (SI) Datasets 1 and 2], resulting in values between 10−6 and 10−1 and most probable values between 10−5 and 10−2 (in units of h·g/mmol). The obtained a is, therefore, within the expected range.Using the reconstructed E. coli MG1655 metabolic network (22) (SI Dataset 1), we first tested the maximal growth rate of E. coli MG1655 cells in various single carbon-limited media and compared the results with the theoretically predicted growth rates (Fig. 1 a is not valid for these two substrates. E. coli is better adapted to growth on glucose, suggesting a smaller average crowding coefficient than in any of the other carbon sources. Indeed, the average crowding coefficient necessary to obtain a perfect agreement for glucose is smaller: a = 0.0031 ± 0.0001 h·g/mmol. In contrast, in some carbon-limited media E. coli reaches its predicted maximal growth rate only after a period of adaptive evolution (23, 24), suggesting a higher average crowding coefficient before metabolic adaptation. Indeed, the average crowding coefficient necessary to obtain a perfect agreement for glycerol is larger: a = 0.0053 ± 0.0001 h·g/mmol.
The FBAwMC framework also allows us to predict the maximal growth rate of microbial strains with deleted metabolic enzymes, by simply removing the corresponding metabolic reaction from the FBAwMC model and recomputing the maximal growth rate. To test the power of this predictive capability we experimentally determined the maximal growth rate of several E. coli MG1655 single gene deletion mutants grown in glucose-limited medium. As shown in Fig. 1 Substrate Hierarchy Utilization by E. coli Cells Growing in Mixed Substrates. Extensive experimental data indicate that when grown in complex media bacterial cells use the available substrates either preferentially or simultaneously (see, e.g., refs. 14, 15, and 17), depending on the growth conditions. To further assess the role of an enzyme concentration limit on cellular metabolism we next examined the substrate utilization of E. coli cells in a mixed carbon-limited medium, and we compared the results to the FBAwMC E. coli model-predicted substrate uptake and utilization (Fig. 2
As typically seen in batch culture, initially E. coli cells showed minimal growth (lag phase) followed by rapid population expansion between 2 and 8 h (exponential growth phase) with no further growth afterward (stationary phase) (Fig. 2 Of the five supplied carbon sources, in the first 3.5 h of growth only glucose was used (phase 1); it was depleted from the medium within the first 4 h (Fig. 2 Subsequently, we tested FBAwMC E. coli model on the mixed-substrate conditions. In contrast with FBA (3, 11), which predicts the simultaneous utilization of all carbon sources, we find a remarkably good correlation between the mode and sequence of FBAwMC-predicted and measured substrate uptake and consumption (Fig. 2 As surrogate markers of cellular metabolism, during the batch culture experiments we also traced the changes in pH and oxygen concentrations in the growth medium. We observed a steady decline in pH during the first 6 h, followed by a slight increase then decrease between 6 and 7 h, and finally an increase between 7 and 8 h (Fig. 2 The Mode and Sequence of Substrate Utilization Correlate with the Expression of Genes Participating in the Uptake Modules. We also prepared mRNA from samples obtained at 30-min intervals between 2 and 8 h and processed them for microarray analysis presented as SI Dataset 3. At the level of substrate uptake pathways (Fig. 3 To assess the quality of the microarray profiles and to identify genes with expression patterns that are similar to those of genes encoding enzymes of the uptake pathways we used TimeSearcher (29). We find that most genes displaying expression patterns similar to those of the query genes are colocalized with them in the same operon (SI Figs. 10–15). For example, for the maltose uptake module genes (malEFGK, malQ, and glk), TimeSearcher identified several other genes (lamB, malM, malP, malS, and malZ) with similar expression profiles. These genes are part of various operons within the maltose regulon (30), although not all of them directly participate in maltose uptake. Similarly, for glycerol metabolism several related glycerol utilization genes (glpA, glpB, glpC, glpD, glpQ, and glpT) displayed expression patterns that were similar to those of the three genes responsible for glycerol uptake (glpF, glpK, and gpsA). The products of these genes are part of the pathway for glycerol catabolism after its uptake. Activation of Stress Programs upon Switching Metabolic Phases. To assess the global state of E. coli transcriptome during the various metabolic phases of the time course experiment, we used three different data analysis methods to analyze the full microarray data. These methods included hierarchical clustering with optimal leaf ordering (31, 32) (Fig. 4
Samples obtained during the mixed-substrate utilization phase (5 and 5.5 h) and the late carbon utilization phase (6.5 h) display similar global expression profiles (Fig. 4 To further characterize the time-point-specific expression profiles, we also prepared mRNA samples from individual mid-logarithmic batch culture E. coli cells (OD600 ≈ 0.2) grown in glucose-, maltose-, glycerol-, acetate-, lactate, or galactose-limited medium, processed them for microarray analysis (presented as SI Datasets 4 and 5), and compared the obtained transcriptome profiles with those of the individual time points (Fig. 4 Discussion A key aim of systems biology is the identification of the organizing principles and fundamental constraints that characterize the function of molecular interaction networks, including those that define cellular metabolism. In the present work we have focused on the identification of principles that define the growth and substrate utilization mode of bacterial cells in complex environments. Our experimental results indicate the occurrence of three major metabolic phases during the growth of E. coli on one type of mixed-substrate medium. Glucose, which by itself provides the highest growth rate, is preferentially used by E. coli, followed by simultaneous utilization of maltose, l-lactate, and galactose. Glycerol and (secreted) acetate are used at a third and final stage of growth. In addition, global mRNA expression data indicate that the organism-level integration of cellular functions in part involves the appearance of partial stress response by E. coli at the boundaries of major metabolic phases, and, as previously shown (35), the activation of a foraging program upon exhaustion of substrates from the growth medium (Fig. 4 The simulation results show that the FBAwMC model introduced here successfully captures all main features of the examined metabolic activities. First, there is a significant correlation between in vivo relative maximal growth rates of E. coli in different carbon-limited media and the in silico predictions of the FBAwMC (Fig. 1 We observe, however, two discrepancies of the FBAwMC model predictions: (i) a higher than predicted amount of secreted acetate in the growth medium, and (ii) a somewhat earlier uptake and consumption of various substrates from the medium compared with that predicted by the model. The first discrepancy is likely rooted on the contribution of other cell components apart from metabolic enzymes. With increasing growth rate higher concentrations of ribosomal proteins, mRNA, and DNA are required in addition to metabolic enzymes (36). This observation indicates that the FBAwMC model may underestimate the impact of macromolecular crowding and the resulting excretion of acetate. The second discrepancy is quite likely a consequence of the first one, as acetate secretion is generally correlated with an increased carbon source uptake rate (27). Taken together, our results show that in silico models incorporating flux balance and other physicochemical constraints can capture increasingly well the metabolic activity of bacterial cells, and that the maximum enzyme concentration is a key constraint shaping the hierarchy of substrate utilization in mixed-substrate growth conditions. Yet, while the metabolic capabilities of a cell are limited by such constraints, in reality any change in metabolic activity is controlled by regulatory mechanisms evolved in the context of these constraints. Therefore, constrained optimization approaches are also expected to help us better understand and/or uncover regulatory mechanisms acting in E. coli and other organisms. Materials and Methods Mathematical Framework. The FBAwMC modeling framework has been established, as described in Results and as detailed in SI Text, S1 and S2. Growth Experiments, Carbon Substrate, and Microarray Analyses. The E. coli K12 strain MG1655 (F− λ− ilvG rfb50 rph1) was used throughout the work. Isogenic E. coli mutants (pgk, atpC, gpmA, nuoA, gdhA, and pfkA) were obtained from F. Blattner (University of Wisconsin, Madison) (37). The experimental details of the growth rate measurements, substrate concentration assays and microarray analyses are detailed in SI Text, S3–S12. Supporting Information
Acknowledgments We thank N. Gerry and M. Lenburg (Boston University, Boston, MA) for their help with microarray experiments, and an anonymous reviewer for comments on the manuscript. Research at the University of Notre Dame and at the University of Pittsburgh was supported by the National Institutes of Health Grant U01 AI070499. Footnotes The authors declare no conflict of interest. This article is a PNAS Direct Submission. This article contains supporting information online at www.pnas.org/cgi/content/full/0609845104/DC1. References 1. Hatzimanikatis V, Li C, Ionita JA, Henry CS, Jankowski MD, Broadbelt LJ. Curr Opin Struct Biol. 2004;14:300–306. [PubMed] 2. Barabási A-L, Oltvai ZN. Nat Rev Genet. 2004;5:101–113. [PubMed] 3. Price ND, Reed JL, Palsson BO. Nat Rev Microbiol. 2004;2:886–897. [PubMed] 4. Segre D, Vitkup D, Church GM. Proc Natl Acad Sci USA. 2002;99:15112–15117. [PubMed] 5. Beard DA, Liang SD, Qian H. Biophys J. 2002;83:79–86. [PubMed] 6. Henry CS, Jankowski MD, Broadbelt LJ, Hatzimanikatis V. Biophys J. 2006;90:1453–1461. [PubMed] 7. Ellis RJ. Trends Biochem Sci. 2001;26:597–604. [PubMed] 8. Hall D, Minton AP. Biochim Biophys Acta. 2003;1649:127–139. [PubMed] 9. Minton AP. J Pharm Sci. 2005;94:1668–1675. [PubMed] 10. Elowitz MB, Surette MG, Wolf PE, Stock JB, Leibler S. J Bacteriol. 1999;181:197–203. [PubMed] 11. Reed JL, Palsson BO. Genome Res. 2004;14:1797–1805. [PubMed] 12. Brown GC. J Theor Biol. 1991;153:195–203. [PubMed] 13. Heinrich R, Schuster S. The Regulation of Cellular Systems. New York: Chapman & Hall; 1996. 14. Harder W, Dijkhuizen L. Philos Trans R Soc London B. 1982;297:459–480. [PubMed] 15. Egli T. Adv Microb Ecol. 1995;14:305–386. 16. Raamsdonk LM, Diderich JA, Kuiper A, van Gaalen M, Kruckeberg AL, Berden JA, Van Dam K. Yeast. 2001;18:1023–1033. [PubMed] 17. Baev MV, Baev D, Radek AJ, Campbell JW. Appl Microbiol Biotechnol. 2006;71:323–328. [PubMed] 18. Zinn M, Witholt B, Egli T. J Biotechnol. 2004;113:263–279. [PubMed] 19. Covert MW, Palsson BO. J Biol Chem. 2002;277:28058–28064. [PubMed] 20. Schilling CH, Palsson BO. Proc Natl Acad Sci USA. 1998;95:4193–4198. [PubMed] 21. Zimmerman SB, Trach SO. J Mol Biol. 1991;222:599–620. [PubMed] 22. Reed JL, Vo TD, Schilling CH, Palsson BO. Genome Biol. 2003;4:R54. [PubMed] 23. Fong SS, Palsson BO. Nat Genet. 2004;36:1056–1058. [PubMed] 24. Ibarra RU, Edwards JS, Palsson BO. Nature. 2002;420:186–189. [PubMed] 25. Thiele I, Vo TD, Price ND, Palsson BO. J Bacteriol. 2005;187:5818–5830. [PubMed] 26. Deutscher D, Meilijson I, Kupiec M, Ruppin E. Nat Genet. 2006;38:993–998. [PubMed] 27. El-Mansi EM, Holms WH. J Gen Microbiol. 1989;135:2875–2883. [PubMed] 28. Reiling HE, Laurila H, Fiechter A. J Biotechnol. 1985;2:191–206. 29. Hochheiser H, Baehrecke E, Mount S, Shneiderman B. Proceedings 2003 International Conference on Multimedia and Expo; Piscataway, NJ: IEEE; 2003. pp. III-453–III-456. 30. Balázsi G, Barabási A-L, Oltvai ZN. Proc Natl Acad Sci USA. 2005;102:7841–7846. [PubMed] 31. Bar-Joseph Z, Gifford DK, Jaakkola TS. Bioinformatics. 2001;17:S22–S29. [PubMed] 32. Eisen MB, Spellman PT, Brown PO, Botstein D. Proc Natl Acad Sci USA. 1998;95:14863–14868. [PubMed] 33. Peterson LE. Comput Methods Programs Biomed. 2003;70:107–119. [PubMed] 34. Ernst J, Vainas O, Harbison CT, Simon I, Bar-Joseph Z. Mol Syst Biol. 2007;3:74. [PubMed] 35. Liu M, Durfee T, Cabrera JE, Zhao K, Jin DJ, Blattner FR. J Biol Chem. 2005;280:15921–15927. [PubMed] 36. Neidhardt FC, Ingraham JL, Schaechter M. Physiology of the Bacterial Cell: A Molecular Approach. Sunderland, MA: Sinauer; 1990. 37. Kang Y, Durfee T, Glasner JD, Qiu Y, Frisch D, Winterberg KM, Blattner FR. J Bacteriol. 2004;186:4921–4930. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Curr Opin Struct Biol. 2004 Jun; 14(3):300-6.
[Curr Opin Struct Biol. 2004]Nat Rev Genet. 2004 Feb; 5(2):101-13.
[Nat Rev Genet. 2004]Nat Rev Microbiol. 2004 Nov; 2(11):886-97.
[Nat Rev Microbiol. 2004]Proc Natl Acad Sci U S A. 2002 Nov 12; 99(23):15112-7.
[Proc Natl Acad Sci U S A. 2002]Biophys J. 2002 Jul; 83(1):79-86.
[Biophys J. 2002]Philos Trans R Soc Lond B Biol Sci. 1982 Jun 11; 297(1088):459-80.
[Philos Trans R Soc Lond B Biol Sci. 1982]Yeast. 2001 Aug; 18(11):1023-33.
[Yeast. 2001]Appl Microbiol Biotechnol. 2006 Jul; 71(3):323-8.
[Appl Microbiol Biotechnol. 2006]J Biotechnol. 2004 Sep 30; 113(1-3):263-79.
[J Biotechnol. 2004]J Biol Chem. 2002 Aug 2; 277(31):28058-64.
[J Biol Chem. 2002]Nat Rev Microbiol. 2004 Nov; 2(11):886-97.
[Nat Rev Microbiol. 2004]Proc Natl Acad Sci U S A. 1998 Apr 14; 95(8):4193-8.
[Proc Natl Acad Sci U S A. 1998]Trends Biochem Sci. 2001 Oct; 26(10):597-604.
[Trends Biochem Sci. 2001]Biochim Biophys Acta. 2003 Jul 30; 1649(2):127-39.
[Biochim Biophys Acta. 2003]J Pharm Sci. 2005 Aug; 94(8):1668-75.
[J Pharm Sci. 2005]J Mol Biol. 1991 Dec 5; 222(3):599-620.
[J Mol Biol. 1991]Genome Biol. 2003; 4(9):R54.
[Genome Biol. 2003]Nat Genet. 2004 Oct; 36(10):1056-8.
[Nat Genet. 2004]Nature. 2002 Nov 14; 420(6912):186-9.
[Nature. 2002]J Bacteriol. 2005 Aug; 187(16):5818-30.
[J Bacteriol. 2005]Nat Genet. 2006 Sep; 38(9):993-8.
[Nat Genet. 2006]Philos Trans R Soc Lond B Biol Sci. 1982 Jun 11; 297(1088):459-80.
[Philos Trans R Soc Lond B Biol Sci. 1982]Appl Microbiol Biotechnol. 2006 Jul; 71(3):323-8.
[Appl Microbiol Biotechnol. 2006]J Gen Microbiol. 1989 Nov; 135(11):2875-83.
[J Gen Microbiol. 1989]Nat Rev Microbiol. 2004 Nov; 2(11):886-97.
[Nat Rev Microbiol. 2004]Genome Res. 2004 Sep; 14(9):1797-805.
[Genome Res. 2004]Proc Natl Acad Sci U S A. 2005 May 31; 102(22):7841-6.
[Proc Natl Acad Sci U S A. 2005]Bioinformatics. 2001; 17 Suppl 1():S22-9.
[Bioinformatics. 2001]Proc Natl Acad Sci U S A. 1998 Dec 8; 95(25):14863-8.
[Proc Natl Acad Sci U S A. 1998]Comput Methods Programs Biomed. 2003 Feb; 70(2):107-19.
[Comput Methods Programs Biomed. 2003]Mol Syst Biol. 2007; 3():74.
[Mol Syst Biol. 2007]Bioinformatics. 2001; 17 Suppl 1():S22-9.
[Bioinformatics. 2001]J Biol Chem. 2005 Apr 22; 280(16):15921-7.
[J Biol Chem. 2005]J Biol Chem. 2005 Apr 22; 280(16):15921-7.
[J Biol Chem. 2005]J Gen Microbiol. 1989 Nov; 135(11):2875-83.
[J Gen Microbiol. 1989]J Bacteriol. 2004 Aug; 186(15):4921-30.
[J Bacteriol. 2004]